371 related articles for article (PubMed ID: 24437518)
1. The ubiquitin-proteasome system in neurodegeneration.
McKinnon C; Tabrizi SJ
Antioxid Redox Signal; 2014 Dec; 21(17):2302-21. PubMed ID: 24437518
[TBL] [Abstract][Full Text] [Related]
2. Failure of ubiquitin proteasome system: risk for neurodegenerative diseases.
Zheng C; Geetha T; Babu JR
Neurodegener Dis; 2014; 14(4):161-75. PubMed ID: 25413678
[TBL] [Abstract][Full Text] [Related]
3. Removing protein aggregates: the role of proteolysis in neurodegeneration.
Nijholt DA; De Kimpe L; Elfrink HL; Hoozemans JJ; Scheper W
Curr Med Chem; 2011; 18(16):2459-76. PubMed ID: 21568912
[TBL] [Abstract][Full Text] [Related]
4. Role for the ubiquitin-proteasome system in Parkinson's disease and other neurodegenerative brain amyloidoses.
Moore DJ; Dawson VL; Dawson TM
Neuromolecular Med; 2003; 4(1-2):95-108. PubMed ID: 14528055
[TBL] [Abstract][Full Text] [Related]
5. Ubiquitin proteasome system as a pharmacological target in neurodegeneration.
Hol EM; Fischer DF; Ovaa H; Scheper W
Expert Rev Neurother; 2006 Sep; 6(9):1337-47. PubMed ID: 17009921
[TBL] [Abstract][Full Text] [Related]
6. The ubiquitin-proteasome system in retinal health and disease.
Campello L; Esteve-Rudd J; Cuenca N; MartÃn-Nieto J
Mol Neurobiol; 2013 Apr; 47(2):790-810. PubMed ID: 23339020
[TBL] [Abstract][Full Text] [Related]
7. Ubiquitin/proteasome pathway impairment in neurodegeneration: therapeutic implications.
Huang Q; Figueiredo-Pereira ME
Apoptosis; 2010 Nov; 15(11):1292-311. PubMed ID: 20131003
[TBL] [Abstract][Full Text] [Related]
8. Prion-mediated neurodegeneration is associated with early impairment of the ubiquitin-proteasome system.
McKinnon C; Goold R; Andre R; Devoy A; Ortega Z; Moonga J; Linehan JM; Brandner S; Lucas JJ; Collinge J; Tabrizi SJ
Acta Neuropathol; 2016 Mar; 131(3):411-25. PubMed ID: 26646779
[TBL] [Abstract][Full Text] [Related]
9. Ubiquitin biology in neurodegenerative disorders: From impairment to therapeutic strategies.
Kumar D; Ambasta RK; Kumar P
Ageing Res Rev; 2020 Aug; 61():101078. PubMed ID: 32407951
[TBL] [Abstract][Full Text] [Related]
10. The ubiquitin proteasome system in neurodegenerative diseases: culprit, accomplice or victim?
Dennissen FJ; Kholod N; van Leeuwen FW
Prog Neurobiol; 2012 Feb; 96(2):190-207. PubMed ID: 22270043
[TBL] [Abstract][Full Text] [Related]
11. The ubiquitin-proteasome system and neurodegenerative disorders.
Layfield R; Lowe J; Bedford L
Essays Biochem; 2005; 41():157-71. PubMed ID: 16250904
[TBL] [Abstract][Full Text] [Related]
12. Protein clearance strategies for disease intervention.
Hommen F; Bilican S; Vilchez D
J Neural Transm (Vienna); 2022 Feb; 129(2):141-172. PubMed ID: 34689261
[TBL] [Abstract][Full Text] [Related]
13. Targeting Ubiquitin-Proteasome Pathway by Natural Products: Novel Therapeutic Strategy for Treatment of Neurodegenerative Diseases.
Momtaz S; Memariani Z; El-Senduny FF; Sanadgol N; Golab F; Katebi M; Abdolghaffari AH; Farzaei MH; Abdollahi M
Front Physiol; 2020; 11():361. PubMed ID: 32411012
[TBL] [Abstract][Full Text] [Related]
14. Proteostasis in neurodegenerative diseases.
Kinger S; Jagtap YA; Kumar P; Choudhary A; Prasad A; Prajapati VK; Kumar A; Mehta G; Mishra A
Adv Clin Chem; 2024; 121():270-333. PubMed ID: 38797543
[TBL] [Abstract][Full Text] [Related]
15. Differential activities of the ubiquitin-proteasome system in neurons versus glia may account for the preferential accumulation of misfolded proteins in neurons.
Tydlacka S; Wang CE; Wang X; Li S; Li XJ
J Neurosci; 2008 Dec; 28(49):13285-95. PubMed ID: 19052220
[TBL] [Abstract][Full Text] [Related]
16. The ubiquitin proteasomal system: a potential target for the management of Alzheimer's disease.
Gadhave K; Bolshette N; Ahire A; Pardeshi R; Thakur K; Trandafir C; Istrate A; Ahmed S; Lahkar M; Muresanu DF; Balea M
J Cell Mol Med; 2016 Jul; 20(7):1392-407. PubMed ID: 27028664
[TBL] [Abstract][Full Text] [Related]
17. The ubiquitin proteasome system as a potential target for the treatment of neurodegenerative diseases.
Ying Z; Wang H; Wang G
Curr Pharm Des; 2013; 19(18):3305-14. PubMed ID: 23151138
[TBL] [Abstract][Full Text] [Related]
18. Does impairment of the ubiquitin-proteasome system or the autophagy-lysosome pathway predispose individuals to neurodegenerative disorders such as Parkinson's disease?
Matsuda N; Tanaka K
J Alzheimers Dis; 2010; 19(1):1-9. PubMed ID: 20061621
[TBL] [Abstract][Full Text] [Related]
19. Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies.
Ciechanover A; Kwon YT
Exp Mol Med; 2015 Mar; 47(3):e147. PubMed ID: 25766616
[TBL] [Abstract][Full Text] [Related]
20. The neuronal ubiquitin-proteasome system: murine models and their neurological phenotype.
van Tijn P; Hol EM; van Leeuwen FW; Fischer DF
Prog Neurobiol; 2008 Jun; 85(2):176-93. PubMed ID: 18448229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
